Antimicrobial use in wean to market pigs in the United States assessed via voluntary sharing

This is our Friday rubric: every week a new Science Page from the Bob Morrison’s Swine Health Monitoring Project. The previous editions of the science page are available on our website.

This wee, Drs. Peter Davies and Randall Singer from the University of Minnesota, share a summary of their publication on the use of antimicrobials in wean-to-market pigs in the United States.

Key Points

  • Obtained data on antimicrobial use in the US swine industry through voluntary and confidential sharing of proprietary data
  • First substantial description of antimicrobial use in US swine beyond FDA sales and distribution data  
  • Critically important classes were only 5% of use, and fluoroquinolones and ceftiofur (drugs of most concern) were <1%
  • The project is ongoing and seeking further participation from interested systems for 2018 to 2020.
Continue reading “Antimicrobial use in wean to market pigs in the United States assessed via voluntary sharing”

Antimicrobial use in wean to market pigs in the United States

Today, we are sharing a publication from Drs. Davies and Singer regarding antimicrobial use in wean-to-market pigs in the United States based on self-reported data from swine producers and veterinarians. This work is published in Zoonoses and Public Health in open access.

Impacts

  • Demonstrates the feasibility of obtaining data on antimicrobial use in the United States swine industry through sharing of proprietary records within industry.
  • Provides the first substantial description of antimicrobial use in United States swine beyond annual sales and distribution data.
  • Indicates that specific metrics of antibiotic use that focus on conditions within individual industries will be most useful to advance stewardship.
Continue reading “Antimicrobial use in wean to market pigs in the United States”